Source: Eur Respir J 2016; 48: 516-525
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Albert Heidi, Nathavitharana Ruvandhi R., Isaacs Chris, Pai Madhukar, Denkinger Claudia M., Boehme Catharina C.. Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?. Eur Respir J 2016; 48: 516-525

Member's Comments

No comment yet.

Related content which might interest you: Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF Source: Eur Respir J 2013; 42: 252-271 Year: 2013 How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries? Source: Eur Respir J 2015; 45: 549-554 Year: 2015 Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? Source: Eur Respir J 2012; 40: 161-168 Year: 2012 Cost–benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals Source: Eur Respir J 2016; 47: 575-587 Year: 2016 Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis Source: Eur Respir J 2013; 42: 708-720 Year: 2013 Early tuberculosis treatment monitoring by Xpert® MTB/RIF Source: Eur Respir J 2012; 39: 1269-1271 Year: 2012 Late Breaking Abstract - The tuberculosis diagnostic evaluation cascade of care at microscopy centers linked to Xpert MTB/RIF hubs in Uganda Source: International Congress 2017 – Update on TB: latest news Year: 2017 Performance of Xpert MTB/RIF Ultra for tuberculosis diagnosis in the context of passive and active case finding Source: Eur Respir J, 58 (6) 2100257; 10.1183/13993003.00257-2021 Year: 2021 Tuberculosis diagnosis in rural Namibia using gene Xpert MTB/RIF testing Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Xpert MTB/RIF Ultra: the long-awaited game changer for tuberculous meningitis? Source: Eur Respir J, 50 (4) 1701201; 10.1183/13993003.01201-2017 Year: 2017 A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying mycobacterium tuberculosis during routine clinical practice Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Use of Xpert MTB/RIF Ultra assays among paediatric tuberculosis experts in Europe Source: Eur Respir J, 51 (5) 1800346; 10.1183/13993003.00346-2018 Year: 2018 Utility of Xpert® MTB/RIF assay for extrapulmonary tuberculosis, a two year study Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Effect of history of tuberculosis on specificity of Xpert MTB/RIF Source: Eur Respir J, 56 (3) 2000343; 10.1183/13993003.00343-2020 Year: 2020 Xpert MTB/RIF testing of pooled induced sputum Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014 Evaluation of Xpert MTB/RIF assay performance in diagnosing extrapulmonary tuberculosis among adults in a tertiary care centre in India Source: Eur Respir J 2014; 44: 1090-1093 Year: 2014 Incremental Yield of Xpert MTB/RIF Ultra over Xpert MTB/RIF in the diagnosis of extra-pulmonary tuberculosis Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020 Clinical utility of the Xpert MTB/RIF test in induced sputum Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Determining the role of Xpert® MTB/RIF in diagnosing tuberculosis in postmortem tissues Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015